Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 2/20 | 0.38 |
| ▸ | ACHE | P22303 | 12/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | BCHE | P06276 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL155558 | 0.82 | ACHE (0.50) | MGLLACHEEPHX1BCHE | |
| Formaldehyde SCHEMBL19181447 | 0.79 | ACHE (0.47) | MGLLACHEEPHX1BCHE | |
| Ethylene Glycol SCHEMBL4172824 | 0.78 | ACHE (0.50) | MGLLACHEEPHX1BCHE | |
| Acetic Acid SCHEMBL27577998 | 0.78 | ACHE (0.46) | MGLLACHEEPHX1BCHE | |
| Carbamic Acid SCHEMBL28326378 | 0.77 | ACHE (0.45) | MGLLACHEEPHX1BCHE | |
| Hydantoin SCHEMBL28089984 | 0.76 | ACHE (0.38) | MGLLACHEEPHX1TP53BCHE | |
| SCHEMBL28237222 | 0.75 | ACHE (0.42) | MGLLACHEEPHX1BCHE | |
| SCHEMBL28857977 | 0.73 | BCHE (0.37) | MGLLACHEEPHX1BCHE | |
| Oxazolidine SCHEMBL5854392 | 0.73 | ACHE (0.36) | MGLLACHEEPHX1BCHE | |
| SCHEMBL17999141 | 0.73 | ACHE (0.34) | MGLLACHEEPHX1BCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230363380-A1 | INSTRINSICALLY ANTIMICROBIAL POROSIC MATRIX COMPOSITES AND METHOD OF MANUFACTURE THEREOF | WILSON JOHN PAUL (US) | 2023-11-16 | — | — | US | claimed |
| US-20220079145-A1 | INSTRINSICALLY ANTIMICROBIAL POROSIC MATRIX COMPOSITES AND METHOD OF MANUFACTURE THEREOF | WILSON JOHN PAUL (US) | 2022-03-17 | — | — | US | claimed |
| US-20180077925-A1 | INSTRINSICALLY ANTIMICROBIAL POROSIC MATRIX COMPOSITES AND METHOD OF MANUFACTURE THEREOF | WILSON JOHN PAUL (US) | 2018-03-22 | — | — | US | claimed |
| EP-3265135-A1 | INSTRINSICALLY ANTIMICROBIAL POROSIC MATRIX COMPOSITES AND METHOD OF MANUFACTURE THEREOF | Wilson, John Paul (US) | 2018-01-10 | — | — | EP | claimed |
| WO-2016144907-A1 | INSTRINSICALLY ANTIMICROBIAL POROSIC MATRIX COMPOSITES AND METHOD OF MANUFACTURE THEREOF | WILSON JOHN PAUL (US) | 2016-09-15 | — | — | WO | claimed |
| US-20230363380-A1 | INSTRINSICALLY ANTIMICROBIAL POROSIC MATRIX COMPOSITES AND METHOD OF MANUFACTURE THEREOF | WILSON JOHN PAUL (US) | 2023-11-16 | — | — | US | disclosed |
| US-11785942-B2 | Instrinsically antimicrobial porosic matrix composites and method of manufacture thereof | WILSON, John Paul (US) | 2023-10-17 | — | — | US | disclosed |
| EP-3265135-B1 | INSTRINSICALLY ANTIMICROBIAL POROSIC MATRIX COMPOSITES AND METHOD OF MANUFACTURE THEREOF | WILSON JOHN PAUL (US) | 2023-06-07 | — | — | EP | disclosed |
| US-20220079145-A1 | INSTRINSICALLY ANTIMICROBIAL POROSIC MATRIX COMPOSITES AND METHOD OF MANUFACTURE THEREOF | WILSON JOHN PAUL (US) | 2022-03-17 | — | — | US | disclosed |
| US-11039611-B2 | Instrinsically antimicrobial porosic matrix composites and method of manufacture thereof | WILSON JOHN PAUL (US) | 2021-06-22 | — | — | US | disclosed |
| US-20200296955-A1 | INSTRINSICALLY ANTIMICROBIAL POROSIC MATRIX COMPOSITES AND METHOD OF MANUFACTURE THEREOF | WILSON JOHN PAUL (US) | 2020-09-24 | — | — | US | disclosed |
| US-10701929-B2 | Instrinsically antimicrobial porosic matrix composites and method of manufacture thereof | WILSON JOHN PAUL (US) | 2020-07-07 | — | — | US | disclosed |
| US-20060246149-A1 | Antimicrobial pigments | MERCK PATENT GMBH (DE) | 2006-11-02 | — | — | US | disclosed |
| EP-1421166-B1 | CAPSULES FOR INCORPORATION INTO DETERGENT OR PERSONAL CARE COMPOSITIONS | UNILEVER NV (NL) | 2006-10-25 | — | — | EP | disclosed |
| US-20060210500-A1 | Formulations | MERCK PATENT GMBH (DE) | 2006-09-21 | — | — | US | disclosed |
| EP-1635771-A2 | COSMETIC FORMULATIONS COMPRISING ANTIMICROBIAL PIGMENTS | MERCK PATENT GmbH (DE) | 2006-03-22 | — | — | EP | disclosed |
| EP-1633818-A2 | ANTIMICROBIAL PIGMENTS | MERCK PATENT GmbH (DE) | 2006-03-15 | — | — | EP | disclosed |
| US-6927201-B2 | Capsules for incorporation into detergent or personal care compositions | UNILEVER HOME & PERSONAL CARE USA DIVISION OF CONOPCO, INC. (US) | 2005-08-09 | — | — | US | disclosed |
| WO-2004092283-A2 | ANTIMICROBIAL PIGMENTS | MERCK PATENT GMBH (DE) | 2004-10-28 | — | — | WO | disclosed |
| WO-2004091567-A2 | COSMETIC FORMULATIONS COMPRISING ANTIMICROBIAL PIGMENTS | MERCK PATENT GMBH (DE) | 2004-10-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060246149-A1 | Antimicrobial pigments | LPO, TYR, CUTA | MGLL 534/4885ACHE 398/4885EPHX1 4843/4885 |
| US-20060210500-A1 | Formulations | TYR, SUCLG1, CYB5R3 | MGLL 232/4885ACHE 209/4885EPHX1 2189/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.